Literature DB >> 14749262

Genetic factors and insulin secretion: gene variants in the IGF genes.

Leen M 't Hart1, Andreas Fritsche, Ingrid Rietveld, Jacqueline M Dekker, Giel Nijpels, Fausto Machicao, Michael Stumvoll, Cornelia M van Duijn, Hans U Häring, Robert J Heine, J Antonie Maassen, Timon W van Haeften.   

Abstract

IGFs are important regulators of pancreatic beta-cell development, growth, and maintenance. Mutations in the IGF genes have been found to be associated with type 2 diabetes, myocardial infarction, birth weight, and obesity. These associations could result from changes in insulin secretion. We have analyzed glucose-stimulated insulin secretion using hyperglycemic clamps in carriers of a CA repeat in the IGF-I promoter and an ApaI polymorphism in the IGF-II gene. Normal and impaired glucose-tolerant subjects (n = 237) were independently recruited from three different populations in the Netherlands and Germany to allow independent replication of associations. Both first- and second-phase insulin secretion were not significantly different between the various IGF-I or IGF-II genotypes. Remarkably, noncarriers of the IGF-I CA repeat allele had both a reduced insulin sensitivity index (ISI) and disposition index (DI), suggesting an altered balance between insulin secretion and insulin action. Other diabetes-related parameters were not significantly different for both the IGF-I and IGF-II gene variant. We conclude that gene variants in the IGF-I and IGF-II genes are not associated with detectable variations in glucose-stimulated insulin secretion in these three independent populations. Further studies are needed to examine the exact contributions of the IGF-I CA repeat alleles to variations in ISI and DI.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14749262     DOI: 10.2337/diabetes.53.2007.s26

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  7 in total

1.  Variants of CDKAL1 and IGF2BP2 affect first-phase insulin secretion during hyperglycaemic clamps.

Authors:  M J Groenewoud; J M Dekker; A Fritsche; E Reiling; G Nijpels; R J Heine; J A Maassen; F Machicao; S A Schäfer; H U Häring; L M 't Hart; T W van Haeften
Journal:  Diabetologia       Date:  2008-07-11       Impact factor: 10.122

Review 2.  Linoleic acid and the regulation of glucose homeostasis: A review of the evidence.

Authors:  Jakob S Hamilton; Eric L Klett
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2021-10-29       Impact factor: 4.006

3.  Type 2 Diabetes Mellitus and the Association of Candidate Genes in Asian Indian Population from Hyderabad, India.

Authors:  Imran Ali Khan; Subhadra Poornima; Parveen Jahan; Pragna Rao; Qurratulain Hasan
Journal:  J Clin Diagn Res       Date:  2015-11-01

4.  A common genetic variant in WFS1 determines impaired glucagon-like peptide-1-induced insulin secretion.

Authors:  S A Schäfer; K Müssig; H Staiger; F Machicao; N Stefan; B Gallwitz; H U Häring; A Fritsche
Journal:  Diabetologia       Date:  2009-03-28       Impact factor: 10.122

Review 5.  Genetics of obesity.

Authors:  Stephen O'Rahilly; I Sadaf Farooqi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

6.  Identification of IGF1, SLC4A4, WWOX, and SFMBT1 as hypertension susceptibility genes in Han Chinese with a genome-wide gene-based association study.

Authors:  Hsin-Chou Yang; Yu-Jen Liang; Jaw-Wen Chen; Kuang-Mao Chiang; Chia-Min Chung; Hung-Yun Ho; Chih-Tai Ting; Tsung-Hsien Lin; Sheng-Hsiung Sheu; Wei-Chuan Tsai; Jyh-Hong Chen; Hsin-Bang Leu; Wei-Hsian Yin; Ting-Yu Chiu; Ching-luan Chern; Shing-Jong Lin; Brian Tomlinson; Youling Guo; Pak C Sham; Stacey S Cherny; Tai Hing Lam; G Neil Thomas; Wen-Harn Pan
Journal:  PLoS One       Date:  2012-03-29       Impact factor: 3.240

7.  Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms.

Authors:  S A Schäfer; O Tschritter; F Machicao; C Thamer; N Stefan; B Gallwitz; J J Holst; J M Dekker; L M 't Hart; L M t'Hart; G Nijpels; T W van Haeften; H U Häring; A Fritsche
Journal:  Diabetologia       Date:  2007-07-28       Impact factor: 10.122

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.